Berberine vs Nattokinase

Mechanism

Berberine activates AMP-activated protein kinase (AMPK), the master metabolic sensor, mimicking many effects of caloric restriction and exercise. It inhibits mitochondrial Complex I, increasing the AMP:ATP ratio which triggers AMPK. Downstream effects include enhanced GLUT4 translocation (glucose uptake), inhibition of HMG-CoA reductase (cholesterol synthesis), upregulation of LDL receptor expression, and suppression of PCSK9. It also modulates gut microbiome composition, increasing short-chain fatty acid-producing bacteria.

Standard Dosing

500mg 2-3x daily (1000-1500mg total)

Timing

With meals or immediately before meals (reduces postprandial glucose spike). Must be taken with food.

Cycle Duration

Cycle 8-12 weeks on, 4 weeks off (or continuous under practitioner supervision)

Side Effects

• GI cramping/diarrhea (dose-dependent)
• Constipation in some
• Abdominal distension
• Potential for hypoglycemia

Contraindications

• Pregnancy (uterotonic — may induce contractions)
• Lactation
• Concurrent use of multiple CYP3A4 metabolized drugs
• Severe liver disease
• Children under 12

Best Stacking Partners

Mechanism

Nattokinase is a fibrinolytic serine protease extracted from natto (fermented soybeans). It directly degrades fibrin (the structural protein of blood clots) through four mechanisms: direct fibrinolysis, enhancement of endogenous tPA (tissue plasminogen activator) production, conversion of prourokinase to urokinase, and degradation of PAI-1 (plasminogen activator inhibitor-1). It also reduces blood viscosity and may inhibit ACE (angiotensin-converting enzyme), providing mild antihypertensive effects.

Standard Dosing

2000-4000 FU (fibrinolytic units) daily, equivalent to 100-200mg

Timing

On empty stomach, between meals or before bed. Morning and evening split dosing for 24-hour fibrinolytic coverage.

Cycle Duration

ongoing

Side Effects

• Easy bruising
• Nosebleeds
• GI upset
• Rare: serious bleeding events

Contraindications

• Active bleeding or bleeding disorders
• Scheduled surgery (discontinue 2+ weeks prior)
• Concurrent anticoagulant/antiplatelet therapy
• Hemorrhagic stroke history
• Soy allergy
• Active bleeding
• Bleeding disorders
• Pre-surgery (stop 2 weeks prior)
• Concurrent anticoagulation therapy without physician supervision

Best Stacking Partners